神经元特异性烯醇化酶在心脏骤停后预后判断中的价值:年龄与ROSC时间的影响
该研究纳入249例院外心脏骤停(OHCA)复苏后入住ICU的患者,用化学发光免疫分析法测心脏骤停后48小时血清NSE,按年龄和ROSC时间四分位分层,评估NSE预测12个月不良预后(CPC 3-5)的能力。12个月预后不良121例(49%)。NSE预测能力在年龄最轻四分位(18-56岁)极好(AUROC 0.91),随年龄增加而变差,在年龄最大四分位(≥72岁)差(AUROC 0.53);在ROSC时间最短四分位(1-13分钟)无价值(AUROC 0.45),随ROSC时间延长而改善,在ROSC时间最长四分位(≥29分钟)好(AUROC 0.84)。提示解读48小时NSE时需结合年龄和ROSC时间。
要点
- 249例OHCA复苏后入住ICU患者,心脏骤停后48小时NSE预测12个月不良预后(CPC 3-5)的总体能力随年龄和ROSC时间分层差异大。
- 年龄18-56岁四分位NSE预测能力极好(AUROC 0.91 [95%CI 0.81-1.00]),72岁及以上四分位差(AUROC 0.53 [0.37-0.70])。
- ROSC时间1-13分钟四分位NSE预测能力无价值(AUROC 0.45 [0.30-0.61]),29分钟及以上四分位好(AUROC 0.84 [0.74-0.95])。
- 12个月预后不良121例(49%),NSE在年轻和ROSC时间长的患者中有用,在老年和ROSC时间短的患者中无用。
适用人群与场景
- 院外心脏骤停(OHCA)复苏后入住ICU的患者249例。
研究设计与关键结果
- 研究类型为队列研究,样本量249例,人群为OHCA复苏后入住ICU患者,干预为用化学发光免疫分析法测心脏骤停后48小时血清NSE,主要终点为12个月不良预后(CPC 3-5)。
- 12个月预后不良121例(49%)。
- 年龄18-56岁四分位NSE预测12个月不良预后的AUROC 0.91(95%CI 0.81-1.00)。
- 年龄72岁及以上四分位NSE预测12个月不良预后的AUROC 0.53(95%CI 0.37-0.70)。
- ROSC时间1-13分钟四分位NSE预测12个月不良预后的AUROC 0.45(95%CI 0.30-0.61)。
- ROSC时间29分钟及以上四分位NSE预测12个月不良预后的AUROC 0.84(95%CI 0.74-0.95)。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心脏骤停后48小时NSE是年轻患者和ROSC时间长患者12个月预后的有用预测指标,但在老年患者或ROSC时间短的患者中不是。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM OF THE STUDY: We evaluated the impact of patient age and time from collapse to return of spontaneous circulation (ROSC) on the prognostic accuracy of neuron specific enolase (NSE) after out-of-hospital cardiac arrest (OHCA).
METHODS: Using electrochemiluminescence immunoassay, we measured serum concentrations of NSE in 249 patients who were admitted to intensive care units after resuscitation from OHCA. In each quartile according to age and time to ROSC, we evaluated the ability of NSE at 48 h after OHCA to predict poor outcome (Cerebral Performance Category 3-5) at 12 months.
RESULTS: The outcome at 12 months was poor in 121 (49%) patients. The prognostic performance of NSE was excellent (area under the receiver operating characteristic curve, AUROC, 0.91 [95% confidence interval, 0.81-1.00]) in the youngest quartile (18-56 years), but worsened with increasing age, and was poor (AUROC 0.53 [0.37-0.70]) in the oldest quartile (72 years or more). The prognostic performance of NSE was worthless (AUROC 0.45 [0.30-0.61]) in the quartile with the shortest time to ROSC (1-13 min), but improved with increasing time to ROSC, and was good (AUROC 0.84 [0.74-0.95]) in the quartile with the longest time to ROSC (29 min or over).
CONCLUSION: NSE at 48 h after OHCA is a useful predictor of 12-month-prognosis in young patients and in patients with a long time from collapse to ROSC, but not in old patients or patients with a short time to ROSC.
参考来源
- Wihersaari L, Tiainen M, Skrifvars MB, et al. Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC. Resuscitation. 2019. PMID: 31022497. doi:10.1016/j.resuscitation.2019.04.021
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。